Cargando…
Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma
BACKGROUND: While most pediatric sarcomas respond to front-line therapy, some bone sarcomas do not show radiographic response like soft-tissue sarcomas (rhabdomyosarccomas) but do show 90% necrosis. Though, new therapies are urgently needed to improve survival and quality of life in pediatric patien...
Autores principales: | Cheng, Lijun, Pandya, Pankita H., Liu, Enze, Chandra, Pooja, Wang, Limei, Murray, Mary E., Carter, Jacquelyn, Ferguson, Michael, Saadatzadeh, Mohammad Reza, Bijangi-Visheshsaraei, Khadijeh, Marshall, Mark, Li, Lang, Pollok, Karen E., Renbarger, Jamie L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357363/ https://www.ncbi.nlm.nih.gov/pubmed/30704460 http://dx.doi.org/10.1186/s12920-018-0456-5 |
Ejemplares similares
-
Precision Medicine Highlights Dysregulation of the CDK4/6 Cell Cycle Regulatory Pathway in Pediatric, Adolescents and Young Adult Sarcomas
por: Barghi, Farinaz, et al.
Publicado: (2022) -
The Role of MDM2 in Promoting Genome Stability versus Instability
por: Saadatzadeh, M. Reza, et al.
Publicado: (2017) -
The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches
por: Pandya, Pankita H., et al.
Publicado: (2016) -
Osteosarcoma-enriched transcripts paradoxically generate osteosarcoma-suppressing extracellular proteins
por: Li, Kexin, et al.
Publicado: (2023) -
Emerging targets for glioblastoma stem cell therapy
por: Safa, Ahmad R., et al.
Publicado: (2016)